# FDA recall D-1348-2015

> **Ucb, Inc** · Class II · drug recall initiated 2015-07-24.

## Product

univasc (moexipril HCl) tablets, 7.5 mg, 100 Ct Bottle, Rx Only. Manufactured for UCB, Inc., Smyrna, GA 30080. NDC: 0091-3707-01.

## Reason for recall

Failed Dissolution Testing: Failed 24 month dissolution testing.

## Distribution

U.S. Nationwide

## Key facts

- **Recall number:** D-1348-2015
- **Recalling firm:** Ucb, Inc
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2015-07-24
- **Report date:** 2015-08-26
- **Termination date:** 2017-07-19

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Smyrna, GA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1348-2015

## Citation

> AI Analytics. FDA recall D-1348-2015. Retrieved 2026-05-28 from https://api.ai-analytics.org/recall/D-1348-2015. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*
